Untangling Amyloidosis 2019 | oneAMYLOIDOSISvoice

Untangling Amyloidosis 2019

Friday, December 06, 2019, 7:00 a.m. – 11:00 a.m.
Orange County Convention Center, W331, Level 3

Karmanos Cancer Institute in collaboration with Amyloidosis Foundation and Amyloidosis Support Group is developing a CME symposium to be conducted on Friday, preceding ASH in December 2019. It will consist of a case-based series of presentations focusing on diagnosing and treating systemic amyloidosis, with a particular emphasis on AL amyloidosis. Recent advances in the therapy of all types of amyloidosis will be discussed during symposium. Invited speakers will present a clinical vignette which raises questions or illustrates key points related to the assigned topic.
Given the importance of multidisciplinary management of amyloidosis, we intend to live-stream the presentations to expand the audience beyond those attending the ASH Annual Meeting. The program is intended to be interactive, and the audience will be asked to provide opinions and answers to questions intermittently throughout the Program via Sync System. A panel discussion after the speakers’ presentations will provide an opportunity to address questions from the live audience


Jeffrey A. Zonder, Barbara Ann Karmanos Cancer Institute / Wayne State University School of Medicine, Detroit, MI


Raymond L Comenzo, MD, Tufts Medical Center, Boston, MA
Martha Grogan, Mayo Clinic, Rochester, MN
Heather J Landau, MD, Memorial Sloan Kettering Cancer Center, New York, NY
Vaishali Sanchorawala, MD, Boston Medical Center, Boston, MA
Stefan Schonland, University Hospital Heidelberg, Heidelberg, Germany
Jeffrey A. Zonder, Karmanos Cancer Institute, Detroit, MI


Silva Pregja, Karmanos Cancer Institute
Email: Pregjas@karmanos.org

This event has ended.

Untangling Amyloidosis 2019


The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.